298 related articles for article (PubMed ID: 31336746)
1. Proteomics in the World of Induced Pluripotent Stem Cells.
Lindoso RS; Kasai-Brunswick TH; Monnerat Cahli G; Collino F; Bastos Carvalho A; Campos de Carvalho AC; Vieyra A
Cells; 2019 Jul; 8(7):. PubMed ID: 31336746
[TBL] [Abstract][Full Text] [Related]
2. Nuclear transcriptome profiling of induced pluripotent stem cells and embryonic stem cells identify non-coding loci resistant to reprogramming.
Fort A; Yamada D; Hashimoto K; Koseki H; Carninci P
Cell Cycle; 2015; 14(8):1148-55. PubMed ID: 25664506
[TBL] [Abstract][Full Text] [Related]
3. Vimentin expression is retained in erythroid cells differentiated from human iPSC and ESC and indicates dysregulation in these cells early in differentiation.
Trakarnsanga K; Ferguson D; Daniels DE; Griffiths RE; Wilson MC; Mordue KE; Gartner A; Andrienko TN; Calvert A; Condie A; McCahill A; Mountford JC; Toye AM; Anstee DJ; Frayne J
Stem Cell Res Ther; 2019 Apr; 10(1):130. PubMed ID: 31036072
[TBL] [Abstract][Full Text] [Related]
4. Concise review: Induced pluripotent stem cells versus embryonic stem cells: close enough or yet too far apart?
Bilic J; Izpisua Belmonte JC
Stem Cells; 2012 Jan; 30(1):33-41. PubMed ID: 22213481
[TBL] [Abstract][Full Text] [Related]
5. Evolution of induced pluripotent stem cell technology.
Zhou H; Ding S
Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
[TBL] [Abstract][Full Text] [Related]
6. Efficient hematopoietic redifferentiation of induced pluripotent stem cells derived from primitive murine bone marrow cells.
Pfaff N; Lachmann N; Kohlscheen S; Sgodda M; Araúzo-Bravo MJ; Greber B; Kues W; Glage S; Baum C; Niemann H; Schambach A; Cantz T; Moritz T
Stem Cells Dev; 2012 Mar; 21(5):689-701. PubMed ID: 21732815
[TBL] [Abstract][Full Text] [Related]
7. Current progress and potential practical application for human pluripotent stem cells.
Philonenko ES; Shutova MV; Chestkov IV; Lagarkova MA; Kiselev SL
Int Rev Cell Mol Biol; 2011; 292():153-96. PubMed ID: 22078961
[TBL] [Abstract][Full Text] [Related]
8. Generation and Proteome Profiling of PBMC-Originated, iPSC-Derived Corneal Endothelial Cells.
Ali M; Khan SY; Vasanth S; Ahmed MR; Chen R; Na CH; Thomson JJ; Qiu C; Gottsch JD; Riazuddin SA
Invest Ophthalmol Vis Sci; 2018 May; 59(6):2437-2444. PubMed ID: 29847650
[TBL] [Abstract][Full Text] [Related]
9. Directed neuronal differentiation of mouse embryonic and induced pluripotent stem cells and their gene expression profiles.
Chen X; Gu Q; Wang X; Ma Q; Tang H; Yan X; Guo X; Yan H; Hao J; Zeng F
Int J Mol Med; 2013 Jul; 32(1):25-34. PubMed ID: 23652807
[TBL] [Abstract][Full Text] [Related]
10. Quantitative proteomic analysis of mouse embryonic fibroblasts and induced pluripotent stem cells using 16O/18O labeling.
Huang X; Tian C; Liu M; Wang Y; Tolmachev AV; Sharma S; Yu F; Fu K; Zheng J; Ding SJ
J Proteome Res; 2012 Apr; 11(4):2091-102. PubMed ID: 22375802
[TBL] [Abstract][Full Text] [Related]
11. Quantitative proteomics of protein complexes and their implications for cell reprograming and pluripotency.
Sudhir PR; Kumari MP; Hsu WT; Massiot J; Chen CH; Kuo HC; Chen CH
J Proteome Res; 2013 Dec; 12(12):5878-90. PubMed ID: 24256468
[TBL] [Abstract][Full Text] [Related]
12. Transcriptome Profiling Reveals Degree of Variability in Induced Pluripotent Stem Cell Lines: Impact for Human Disease Modeling.
Schuster J; Halvardson J; Pilar Lorenzo L; Ameur A; Sobol M; Raykova D; Annerén G; Feuk L; Dahl N
Cell Reprogram; 2015 Oct; 17(5):327-37. PubMed ID: 26348590
[TBL] [Abstract][Full Text] [Related]
13. Embryo-derived and induced pluripotent stem cells: Towards naive pluripotency and chimeric competency in rabbits.
Afanassieff M; Perold F; Bouchereau W; Cadiou A; Beaujean N
Exp Cell Res; 2020 Apr; 389(2):111908. PubMed ID: 32057751
[TBL] [Abstract][Full Text] [Related]
14. The Expression and Functional Roles of miRNAs in Embryonic and Lineage-Specific Stem Cells.
Farzaneh M; Alishahi M; Derakhshan Z; Sarani NH; Attari F; Khoshnam SE
Curr Stem Cell Res Ther; 2019; 14(3):278-289. PubMed ID: 30674265
[TBL] [Abstract][Full Text] [Related]
15. Present and future challenges of induced pluripotent stem cells.
Ohnuki M; Takahashi K
Philos Trans R Soc Lond B Biol Sci; 2015 Oct; 370(1680):20140367. PubMed ID: 26416678
[TBL] [Abstract][Full Text] [Related]
16. Quantitative proteome and phosphoproteome analysis of human pluripotent stem cells.
Muñoz J; Heck AJ
Methods Mol Biol; 2011; 767():297-312. PubMed ID: 21822884
[TBL] [Abstract][Full Text] [Related]
17. Increased efficiency in the generation of induced pluripotent stem cells by Fbxw7 ablation.
Okita Y; Matsumoto A; Yumimoto K; Isoshita R; Nakayama KI
Genes Cells; 2012 Sep; 17(9):768-77. PubMed ID: 22897623
[TBL] [Abstract][Full Text] [Related]
18. Integrative omics connects N-glycoproteome-wide alterations with pathways and regulatory events in induced pluripotent stem cells.
Sudhir PR; Kumari MP; Hsu WT; Chen CH; Kuo HC; Chen CH
Sci Rep; 2016 Nov; 6():36109. PubMed ID: 27808266
[TBL] [Abstract][Full Text] [Related]
19. Quantifying signaling pathway activation to monitor the quality of induced pluripotent stem cells.
Makarev E; Fortney K; Litovchenko M; Braunewell KH; Zhavoronkov A; Atala A
Oncotarget; 2015 Sep; 6(27):23204-12. PubMed ID: 26327604
[TBL] [Abstract][Full Text] [Related]
20. Comparative proteome and transcriptome analyses of embryonic stem cells during embryoid body-based differentiation.
Fathi A; Pakzad M; Taei A; Brink TC; Pirhaji L; Ruiz G; Sharif Tabe Bordbar M; Gourabi H; Adjaye J; Baharvand H; Salekdeh GH
Proteomics; 2009 Nov; 9(21):4859-70. PubMed ID: 19862760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
